酒精相关的肝病:新兴的治疗策略
Benjamin H Mullish1,2, Mark R Thursz1,2
1Section of Hepatology and Gastroenterology, Department of Metabolism, Digestion and Reproduction, Division of Digestive Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.
Hepatology (Baltimore, Md.)
|June 26, 2024
概括
酒精相关性肝病 (ALD) 研究重点是针对酒精相关性肝炎 (AH) 的新疗法. 新兴疗法包括细胞因子操纵,表观遗传调节和便微生物群移植,以及不断发展的肝移植标准.
科学领域:
- 肝病学和成医学 肝病学和成医学
背景情况:
- 与酒精相关的肝病 (ALD) 和与酒精相关的肝炎 (AH) 的负担日益增加,需要新的治疗策略.
- 酒精使用障碍的管理至关重要,肝脏病学和成服务在同一位置显示出更好的结果.
- 由于感染风险和有限的缓解策略,在严重的AH中使用皮质类固醇需要仔细监测.
研究的目的:
- 审查酒精相关肝炎 (AH) 的当前和新兴治疗策略.
- 在ALD护理的背景下,讨论管理酒精使用障碍的进展.
- 探索严重的AH中肝移植的不断变化的作用和选择标准.
主要方法:
- 对有关酒精相关肝病和酒精相关肝炎管理的当前文献的综述.
- 对新型治疗方法的证据分析,包括细胞因子操纵,表观遗传调制和肠道微生物群向.
- 检查正在发展的实践和证据,关于早期肝移植严重的AH.
主要成果:
- 为酒精使用障碍管理建立了基于证据的方法,服务的共同定位提高了结果.
- 开发用于评估皮质类固醇反应和预测AH感染风险的工具.
- 从针对炎症和肠道微生物组的新疗法获得有希望的早期结果.
结论:
- 对于AH的新型治疗途径正在取得进展,提供超出目前管理的潜力.
- 早期肝移植治疗严重的肝炎正在获得接受,挑战了传统的清醒要求,尽管选择标准需要进一步定义.
- 为了完善与酒精相关的肝病和与酒精相关的肝炎的治疗模式,继续进行研究至关重要.
相关概念视频
01:27CNS Depressants: Alcohol and Nicotine
201
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
201
01:29Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84
01:22Alzheimer's Disease: Treatment
178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125